inhibitors of the Bcl-2 family of antiapoptotic proteins (ASINEX)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinhibitors of the Bcl-2 family of antiapoptotic proteins (ASINEX)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator Bcl-X inhibitorsInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors
TargetsInduced myeloid leukemia cell differentiation protein Mcl-1Apoptosis regulator Bcl-X
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesASINEX Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesASINEX Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A